| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9382 |
| Human Intestinal Absorption | HIA+ | 0.9475 |
| Caco-2 Permeability | Caco2+ | 0.6912 |
| P-glycoprotein Substrate | Non-substrate | 0.6589 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9007 |
| Non-inhibitor | 0.8734 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9077 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9286 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7947 |
| CYP450 2D6 Substrate | Non-substrate | 0.9051 |
| CYP450 3A4 Substrate | Non-substrate | 0.6600 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8307 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7269 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9208 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9131 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9378 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9156 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9858 |
| Non-inhibitor | 0.9699 |
| AMES Toxicity | Non AMES toxic | 0.9398 |
| Carcinogens | Non-carcinogens | 0.6523 |
| Fish Toxicity | High FHMT | 0.9755 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9808 |
| Honey Bee Toxicity | High HBT | 0.6040 |
| Biodegradation | Ready biodegradable | 0.8383 |
| Acute Oral Toxicity | IV | 0.5774 |
| Carcinogenicity (Three-class) | Non-required | 0.7033 |